CSI Market
Sign In | Register

Bolt Biotherapeutics Inc (BOLT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BOLT Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Bolt Biotherapeutics Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-14.96
Depreciation & amortization0.37
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.81
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.40
Share-based Compensation1.10
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Business Combination Contingent Consideration Arrangements Increase In Amount Of Contingent Consideration Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-1.20
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.16
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.12
Payments for (Proceeds from) Other Operating Activities-1.36
Discontinued operations0.00
Net Cash flow from Operating Activities-14.56
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.72
Proceeds from Sale and Maturity of Marketable Securities16.22
Payments to Acquire Marketable Securities-1.23
Real Estate Investments0.00
Earnout Payments-
Proceeds From Condemnation Settlement Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities15.70
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.03
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options13.44
Tax Liability From Restricted Stock And Stock Options Exercised-
Dividends And Interest Paid-
Stock Issued During Period Value Stock Options Exercised-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-13.86
Total Cash Flow1.16
4 historic quarters locked

Sign in to unlock the full Bolt Biotherapeutics Inc cash flow history.

Sign In Create Free Account

About Bolt Biotherapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-344597

Figures are derived from filed reports and may be restated. Historical data is subject to revision.